On 23 July 2026, NOVOSENSE convened its Extraordinary Shareholders’ Meeting in Suzhou, securing overwhelming approval for a series of equity incentive resolutions designed to underpin the company’s 2026 talent-retention plans.

A total of 344 shareholders or proxies, representing 74.05 million voting shares (45.67 % of the 162.13 million eligible shares), participated through a combination of on-site and online voting. All nine board directors were in attendance, and the meeting was chaired by Executive Director and Chairman Wang Shengyang.

Key resolutions and voting results: • 2026 A-Share Restricted Share Incentive Scheme and related implementation measures each received 99.76 % support (73.87 million votes in favour, 0.18 million against). • Authorisation for the board to handle matters related to the A-Share scheme passed with 99.76 % approval. • The new 2026 H-Share Scheme and its parameters were endorsed with at least 99.49 % support. • The board and scheme administrator were authorised to execute the H-Share scheme with 99.76 % approval.

Capital base and mandate limits: • NOVOSENSE has 163.51 million issued shares, comprising 143.41 million A-shares and 20.10 million H-shares. After excluding 1.37 million treasury shares, 162.13 million shares carried voting rights at the meeting. • Under the approved H-Share Scheme, the overall scheme mandate is capped at 16.21 million shares (10 % of the class excluding treasury shares). Within this, a service-provider sub-limit of 3.24 million H-shares (2 % of class) applies.

Legal and procedural validation: Computershare Hong Kong Investor Services oversaw vote tabulation, while Jia Yuan Law Offices confirmed that meeting procedures, attendee qualifications and voting processes complied with PRC Company Law and the company’s Articles of Association. All special resolutions therefore stand as legally valid and effective.